ASX-listed ResMed gains most in nearly 4-1/2 months on strong quarterly numbers

ResMed

29/10/2021 01:40

** ASX-listed shares of U.S.-based ResMed Inc  RMD.AX 
 RMD.N  surge as much as 7.7% to A$38.41, their biggest intraday
pct gain since June 15
    ** The medical device maker's first-quarter revenue https://www.asx.com.au/asxpdf/20211029/pdf/45296bpy24wg58.pdf
 up 20% to $904 mln
    ** Increased demand for its sleep and respiratory care
devices was further pushed by recall of Philip's DreamStation, a
rival device 
    ** Non-GAAP income net income for the quarter up 20% to $222
mln
    ** RMD declares quarterly cash dividend of $0.42 per share
    ** Stock hits its highest level since Sept 27
    ** RMD stock up 31% this year, as of last close
   
  

 (Reporting by Dhriti Garg in Bengaluru)
 ((dhriti.garg@thomsonreuters.com))